Literature DB >> 18234431

Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy.

Chunhui Han1, Yi-Jen Chen, An Liu, Timothy E Schultheiss, Jeffrey Y C Wong.   

Abstract

PURPOSE: For intensity-modulated radiotherapy of nasopharyngeal cancer, accurate dose delivery is crucial to the success of treatment. This study aimed to evaluate the significance of daily image-guided patient setup corrections and to quantify the parotid gland volume and dose variations for nasopharyngeal cancer patients using helical tomotherapy megavoltage computed tomography (CT). METHODS AND MATERIALS: Five nasopharyngeal cancer patients who underwent helical tomotherapy were selected retrospectively. Each patient had received 70 Gy in 35 fractions. Daily megavoltage CT scans were registered with the planning CT images to correct the patient setup errors. Contours of the spinal cord and parotid glands were drawn on the megavoltage CT images at fixed treatment intervals. The actual doses delivered to the critical structures were calculated using the helical tomotherapy Planned Adaptive application.
RESULTS: The maximal dose to the spinal cord showed a significant increase and greater variation without daily setup corrections. The significant decrease in the parotid gland volume led to a greater median dose in the later phase of treatment. The average parotid gland volume had decreased from 20.5 to 13.2 cm3 by the end of treatment. On average, the median dose to the parotid glands was 83 cGy and 145 cGy for the first and the last treatment fractions, respectively.
CONCLUSIONS: Daily image-guided setup corrections can eliminate significant dose variations to critical structures. Constant monitoring of patient anatomic changes and selective replanning should be used during radiotherapy to avoid critical structure complications.

Entities:  

Mesh:

Year:  2008        PMID: 18234431     DOI: 10.1016/j.ijrobp.2007.10.067

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  44 in total

1.  Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy.

Authors:  G Sanguineti; F Ricchetti; O Thomas; B Wu; T McNutt
Journal:  Br J Radiol       Date:  2013-09-12       Impact factor: 3.039

2.  Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy.

Authors:  C Yip; C Thomas; A Michaelidou; D James; R Lynn; M Lei; T Guerrero Urbano
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

Review 3.  Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature.

Authors:  S W Loo; W M C Martin; P Smith; S Cherian; T W Roques
Journal:  Br J Radiol       Date:  2012-08       Impact factor: 3.039

4.  Head and neck intensity modulated radiotherapy parotid glands: time of re-planning.

Authors:  Alba Fiorentino; Mariella Cozzolino; Rocchina Caivano; Piernicola Pedicini; Caterina Oliviero; Costanza Chiumento; Stefania Clemente; Vincenzo Fusco
Journal:  Radiol Med       Date:  2013-12-12       Impact factor: 3.469

5.  Effects of remedies made in patient setup process on residual setup errors and margins in head and neck cancer radiotherapy based on 2D image guidance.

Authors:  Mika Kapanen; Marko Laaksomaa; Tapio Tulijoki; Pirkko-Liisa Kellokumpu-Lehtinen; Simo Hyödynmaa
Journal:  Rep Pract Oncol Radiother       Date:  2015-04-01

6.  Clinical outcomes of adaptive radiotherapy in head and neck cancers.

Authors:  Tejinder Kataria; Deepak Gupta; Shikha Goyal; Shyam S Bisht; Trinanjan Basu; Ashu Abhishek; Kushal Narang; Susovan Banerjee; Shahida Nasreen; Sasikumar Sambasivam; Aruj Dhyani
Journal:  Br J Radiol       Date:  2016-03-17       Impact factor: 3.039

7.  Evaluation on lung cancer patients' adaptive planning of TomoTherapy utilising radiobiological measures and Planned Adaptive module.

Authors:  Fan-Chi Su; Chengyu Shi; Panayiotis Mavroidis; Prema Rassiah-Szegedi; Niko Papanikolaou
Journal:  J Radiother Pract       Date:  2009-01-01

8.  Cone-beam computed tomography dose monitoring during intensity-modulated radiotherapy in head and neck cancer: parotid glands.

Authors:  A Fiorentino; M Cozzolino; R Caivano; P Pedicini; C Chiumento; C Oliviero; S Clemente; V Fusco
Journal:  Clin Transl Oncol       Date:  2012-10-13       Impact factor: 3.405

9.  Use of kilovoltage X-ray volume imaging in patient dose calculation for head-and-neck and partial brain radiation therapy.

Authors:  Weigang Hu; Jinsong Ye; Jiazhou Wang; Xuejun Ma; Zhen Zhang
Journal:  Radiat Oncol       Date:  2010-04-19       Impact factor: 3.481

10.  Impact of residual setup error on parotid gland dose in intensity-modulated radiation therapy with or without planning organ-at-risk margin.

Authors:  Anna Delana; Loris Menegotti; Andrea Bolner; Luigi Tomio; Aldo Valentini; Frank Lohr; Valentina Vanoni
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.